Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Feihl

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Revue Medicale Suisse|February 17, 2009
[The ACCOMPLISH trial: are results really unexpected?]Bernard Waeber, François Feihl
The Journal of Emergency Medicine|July 17, 2003
ST segment artifact mimicking coronary ischemic syndromeDamien Tagan, François Feihl
European Heart Journal|October 9, 2012
Plasma renin levels: the lower the better in terms of cardiovascular risk?Bernard Waeber, François Feihl
Lancet (London, England)|June 3, 2014
Nebivolol and valsartan: useful treatment for hypertension?Bernard Waeber, François Feihl
Revue Medicale Suisse|October 25, 2007
[Stratification of global cardiovascular risk according to the ESH/ESC guidelines]Bernard Waeber, François Feihl
Current Hypertension Reports|August 3, 2005
Oxidative stress: a pivotal link among cardiovascular risk factors?Bernard Waeber, François Feihl
Revue Medicale Suisse|October 25, 2007
[Antihypertensive therapy according to the ESH/ESC guidelines]Bernard Waeber, François Feihl
Hypertension (Dallas, Tex. : 1979)|August 7, 2013
Do optimal antihypertensive drug regimens allow blood pressure normalization in all patients with resistant hypertension?Bernard Waeber, François Feihl
Journal of Hypertension|November 8, 2014
Can the development of severe hypertension be predicted?Bernard Waeber, François Feihl
Journal of Hypertension|April 5, 2013
The need for hospitalization still represents a major burden for hypertensive patients and healthcare systemsBernard Waeber, François Feihl
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Revue Medicale Suisse|February 17, 2009
[The ACCOMPLISH trial: are results really unexpected?]Bernard Waeber, François Feihl
The Journal of Emergency Medicine|July 17, 2003
ST segment artifact mimicking coronary ischemic syndromeDamien Tagan, François Feihl
European Heart Journal|October 9, 2012
Plasma renin levels: the lower the better in terms of cardiovascular risk?Bernard Waeber, François Feihl
Lancet (London, England)|June 3, 2014
Nebivolol and valsartan: useful treatment for hypertension?Bernard Waeber, François Feihl
Revue Medicale Suisse|October 25, 2007
[Stratification of global cardiovascular risk according to the ESH/ESC guidelines]Bernard Waeber, François Feihl
Current Hypertension Reports|August 3, 2005
Oxidative stress: a pivotal link among cardiovascular risk factors?Bernard Waeber, François Feihl
Revue Medicale Suisse|October 25, 2007
[Antihypertensive therapy according to the ESH/ESC guidelines]Bernard Waeber, François Feihl
Hypertension (Dallas, Tex. : 1979)|August 7, 2013
Do optimal antihypertensive drug regimens allow blood pressure normalization in all patients with resistant hypertension?Bernard Waeber, François Feihl
Journal of Hypertension|November 8, 2014
Can the development of severe hypertension be predicted?Bernard Waeber, François Feihl
Journal of Hypertension|April 5, 2013
The need for hospitalization still represents a major burden for hypertensive patients and healthcare systemsBernard Waeber, François Feihl
Pageof 9